Table: Anest Iwata -2022/23 group results
May 9 (Reuters)-
Anest Iwata Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2023 Mar 31, 2022 Mar 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 48.52 42.34 51.80 25.70
(+14.6 pct) (+19.0 pct) (+6.8 pct) (+13.6 pct)
Operating 5.84 4.78 6.10 2.78
(+22.1 pct) (+38.8 pct) (+4.5 pct) (+18.8 pct)
Recurring 7.04 5.57 7.10 3.24
(+26.4 pct) (+31.0 pct) (+0.8 pct) (+4.6 pct)
Net
Net 4.38 3.54 4.41 2.00
(+23.7 pct) (+35.0 pct) (+0.6 pct) (+1.3 pct)
EPS 108.25 yen 86.32 yen 108.44 yen 49.21 yen
Ann Div 38.00 yen 30.00 yen 40.00 yen
-Q2 Div 16.00 yen 13.00 yen 17.00 yen
-Q4 Div 22.00 yen 17.00 yen 23.00 yen
NOTE - Anest Iwata Corp.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6381.T
Recent news on Anest Iwata
See all newsBrief: Anest Iwata Corp - To Buy Back Up To 2.53% Own Shares Worth 1.5 Billion Yen
Table: Anest Iwata -2025/26 group results
Table: Anest Iwata -2025/26 parent results
Brief: China's Chery, Japan's Autobacs Seven Have Set Up JV To Sell Electric Vehicles In Japan From 2027, Nikkei Says
Table: Anest Iwata - 9-MTH group results